Position in AZN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,006,317,132
+$88,801,176 QoQ
Shares Held
5,307,020
+14.1% QoQ
Ownership
0.342%
of shares outstanding
% of Portfolio
0.45%
of 13F equity value
Holder Rank
#38
of 1,462 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 82%
Shared 0%
None 18%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $3,542,546,853 across 13 Drug Manufacturers - General names. AZN ranks #1 (28.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
This page
|
5,307,020 | $1,006,317,132 | |
| 2 | MRK |
Merck & Co., Inc.
|
3,966,523 | $509,698,205 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
8,585,846 | $494,716,446 | |
| 4 | NVO |
Novo Nordisk A S
|
8,270,785 | $396,501,432 | |
| 5 | LLY |
ELI LILLY & Co
|
249,935 | $299,779,562 | |
| 6 | JNJ |
Johnson & Johnson
|
1,127,893 | $286,450,985 | |
| 7 | ABBV |
AbbVie Inc.
|
856,797 | $215,604,397 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
959,904 | $121,274,271 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,006,317,132 | 5,307,020 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $917,515,956 | 4,652,246 | Shares | Defined | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||